Holen Sie sich die Stockscreener-App
34.36
0.88%
0.30
Handel nachbörslich:
34.36
Schlusskurs vom Vortag:
$34.06
Offen:
$34.03
24-Stunden-Volumen:
110.78K
Relative Volume:
0.37
Marktkapitalisierung:
$1.39B
Einnahmen:
$1.50B
Nettoeinkommen (Verlust:
$95.23M
KGV:
14.76
EPS:
2.328
Netto-Cashflow:
$12.77M
1W Leistung:
+0.20%
1M Leistung:
+4.00%
6M Leistung:
-34.25%
1J Leistung:
+12.40%
1-Tages-Spanne:
$34.03
$34.68
1-Wochen-Bereich:
$32.88
$35.15
52-Wochen-Spanne:
$28.25
$60.08
Phibro Animal Health Corp Stock (PAHC) Company Profile
Firmenname
Phibro Animal Health Corp
Sektor
Telefon
201-329-7300
Adresse
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC vs TAK, TEVA, HLN, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
34.36 | 1.37B | 1.50B | 95.23M | 12.77M | 2.328 |
TAK
Takeda Pharmaceutical Co Adr
|
17.63 | 55.60B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.77 | 42.81B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.70 | 43.16B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
73.79 | 30.39B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
499.73 | 21.95B | 3.17B | 1.29B | 1.01B | 27.09 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-15 | Eingeleitet | Citigroup | Neutral |
| 2025-07-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-06-16 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2024-09-10 | Eingeleitet | JP Morgan | Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2022-12-21 | Eingeleitet | ROTH Capital | Buy |
| 2022-07-25 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-07-07 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-08-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2020-01-28 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-09-05 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | Bestätigt | BofA/Merrill | Underperform |
| 2019-06-11 | Eingeleitet | Barclays | Underweight |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-05-09 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2017-08-23 | Fortgesetzt | BofA/Merrill | Underperform |
| 2017-06-02 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-11-11 | Herabstufung | Macquarie | Neutral → Underperform |
| 2016-11-10 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2016-04-11 | Bestätigt | Guggenheim | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2016-01-15 | Herabstufung | Barclays | Overweight → Underweight |
| 2015-09-30 | Eingeleitet | Gabelli & Co | Buy |
| 2015-04-24 | Bestätigt | Barclays | Overweight |
| 2015-04-21 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | Eingeleitet | Barclays | Overweight |
Alle ansehen
Phibro Animal Health Corp Aktie (PAHC) Neueste Nachrichten
Phibro Animal Health Corporation (NASDAQ:PAHC) Given Average Recommendation of "Hold" by Brokerages - marketbeat.com
Phibro Animal Health (NASDAQ:PAHC) Shares Cross Below 200 Day Moving AverageHere's What Happened - marketbeat.com
Phibro Animal Health (PAHC) Stock Looks Undervalued On Earnings Yet Mixed Elsewhere - simplywall.st
All News for PAHC : Phibro Animal Health - Zacks Investment Research
Phibro Animal Health CFO David Glenn Awarded 3,334 RSUs on August 6, 2026 - Kalkine Media
Phibro Animal Health (NASDAQ: PAHC) awards 1,503 RSUs to VP Finance - Stock Titan
Phibro Animal Health (NASDAQ: PAHC) CFO receives 3,334-share restricted stock grant - Stock Titan
Phibro Animal Health (PAHC) awards 3,522 RSUs to Chief Operating Officer - Stock Titan
Phibro Animal Health (PAHC) grants 2,716 RSUs to director Jonathan Bendheim - Stock Titan
Phibro Animal Health (NASDAQ: PAHC) awards 2,478 RSUs to senior legal officer - Stock Titan
Phibro Animal Health (PAHC) grants 12,103 RSUs to Executive Chairman Bendheim - Stock Titan
Phibro Animal Health (PAHC) awards 1,547 RSUs to SVP of Human Resources - Stock Titan
Phibro Animal Health (PAHC) grants 11,699 RSUs to President and CEO - Stock Titan
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - Yahoo Finance
Phibro Animal Health Corporatio (PAHC) Stock Forecasts - Yahoo! Finance Canada
Phibro Animal Health (PAHC) HR chief sells 265 shares to cover tax withholding - Stock Titan
CEO of Phibro Animal Health (NASDAQ: PAHC) sells 486 shares for taxes - Stock Titan
Phibro Animal Health (PAHC) CFO sells 840 shares to cover taxes - Stock Titan
Phibro Animal Health (PAHC) chair disposes 2,303 shares to cover tax withholding - Stock Titan
FMR LLC discloses 15% ownership of Phibro Animal Health (PAHC) Class A shares - Stock Titan
Phibro Animal Health Corp at Bank of America Global Healthcare Conference Transcript - GuruFocus
Q3 2026 Phibro Animal Health Corp Earnings Call Transcript - GuruFocus
MILLENNIUM MANAGEMENT LLC Adds to Phibro Animal Health Corp (PAH - GuruFocus
PHIBRO ANIMAL HEALTH CORP SEC Filing (Aug 4, 2026) - Stock Titan
Arrowstreet Capital Limited Partnership Sells 114,947 Shares of Phibro Animal Health Corporation $PAHC - marketbeat.com
PAHC|Phibro Animal Health Corp|Price:37.075|Chg%:+0.745 - TradingKey
Millennium group (NASDAQ: PAHC) discloses 1.06M-share Phibro Animal Health position - Stock Titan
PAHC Looks 23.4% Overvalued on GF Value™ - GuruFocus
Renaissance Technologies LLC Acquires 31,435 Shares of Phibro Animal Health Corporation $PAHC - marketbeat.com
Phibro Animal Health declares $0.12 quarterly dividend payable Sept. 23 - tradingview.com
SummitTX Capital L.P. Purchases 40,102 Shares of Phibro Animal Health Corporation $PAHC - marketbeat.com
PAHC|Phibro Animal Health Corp|Price:34.035|Chg%:-0.005 - TradingKey
Phibro Animal Health Corp (PAHC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Phibro Animal Health Corp (PAHC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Phibro Animal Health Corp (PAHC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Phibro Animal Health Corp (PAHC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Phibro Animal Health Corp (PAHC) Valuation: PE, PB & Fair Value Analysis - TradingKey
PAHC|Phibro Animal Health Corp|Price:35.240|Chg%:+1.205 - TradingKey
TradingKey - TradingKey
Phibro Animal Health Corp (PAHC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Phibro Animal Health Corp (PAHC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now? - Yahoo Finance Australia
Phibro Animal Health Corporation (NASDAQ:PAHC) Receives Consensus Recommendation of "Hold" from Analysts - marketbeat.com
Phibro Animal Health Corp (PAHC) Shares Fall 3.5% -- GF Value Sa - GuruFocus
Phibro Animal Health (PAHC) Stock Looks Reasonable On Value But Stretched After 138% Gain - Yahoo Finance
Phibro Animal Health (PAHC) Leaves Russell Indexes, Is The Stock A Bargain? - Yahoo Finance
Las ETF que invierten en acciones de Phibro Animal Health Corporation Class A - TradingView
Phibro Animal Health (PAHC) Stock Loses Russell Index Spots And Investor Visibility - Yahoo Finance
MSN Money - MSN
Implied Volatility Surging for Phibro Animal Health Stock Options - Yahoo Finance
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo! Finance Canada
Finanzdaten der Phibro Animal Health Corp-Aktie (PAHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.79%
5.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):